Emerging therapeutic options for refractory gout

Nature Reviews Rheumatology, Published online: 15 December 2023; doi:10.1038/s41584-023-01066-5For individuals with gout, the treatment options beyond conventional urate-lowering therapies are expanding. Notable advancements in 2023 include developments in uricase therapy, new xanthine oxidase inhibitors, and a class of medications that offer dual benefits for the control of type 2 diabetes mellitus and gout.
Source: Nature Reviews Rheumatology - Category: Rheumatology Authors: Source Type: research